ArticleJournal of internal medicine2022

Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.

Sebastian Havervall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.